Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Cancer Research UK
Essen Biotech
Colorado State University
Mayo Clinic
Cancer Research UK
Incyte Corporation
University of Alabama at Birmingham
Baxter Healthcare Corporation
Compugen Ltd
Universidade Federal de Pernambuco
Cyteir Therapeutics, Inc.
Gilead Sciences
Scripps Health
Celgene
Shenzhen BinDeBio Ltd.
Masonic Cancer Center, University of Minnesota
Amgen
OHSU Knight Cancer Institute
Ohio State University Comprehensive Cancer Center
Rutgers, The State University of New Jersey
Shenzhen Second People's Hospital
Celldex Therapeutics
Barbara Ann Karmanos Cancer Institute
AHS Cancer Control Alberta
Indiana University
National Cancer Institute (NCI)
University of Kentucky
National Cancer Institute (NCI)
UNC Lineberger Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
AstraZeneca
Fred Hutchinson Cancer Center